Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,681,475
+$2,987,179 QoQ
Shares Held
7,238
+16.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#1,341
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisory Alpha, LLC holds $20,079,575 across 8 Drug Manufacturers - General names. LLY ranks #1 (43.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
7,238 | $8,681,475 | |
| 2 | JNJ |
Johnson & Johnson
|
22,094 | $5,611,213 | |
| 3 | ABBV |
AbbVie Inc.
|
9,774 | $2,459,529 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,797 | $1,130,414 | |
| 5 | PFE |
Pfizer Inc
|
42,927 | $1,033,682 | |
| 6 | AMGN |
Amgen Inc
|
1,326 | $480,171 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,527 | $376,085 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,430 | $307,006 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,681,475 | 7,238 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $5,694,296 | 6,191 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,491,067 | 6,040 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $4,005,750 | 5,250 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,620,916 | 4,645 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $3,442,392 | 4,168 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $2,895,772 | 3,751 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $3,205,330 | 3,618 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,904,459 | 3,208 | Shares | Sole | 2024-08-21 | |
| 2024-03-31 | $2,343,993 | 3,013 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $939,667 | 1,612 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $426,481 | 794 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $4,673,854 | 9,966 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $3,410,504 | 9,931 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $3,604,621 | 9,853 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $3,146,518 | 9,731 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $3,165,781 | 9,764 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $2,813,585 | 9,825 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,688,449 | 9,733 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,230,556 | 9,654 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,210,277 | 9,630 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,798,329 | 9,626 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,636,228 | 9,691 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,425,136 | 9,628 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,583,187 | 9,643 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $185,884 | 1,340 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||